J. Wright

Anticancer Activity of BIM-46174, a New Inhibitor of the Heterotrimeric Gα/Gβγ Protein Complex

D. Zaharevitz, E. Bruyneel, S. Holbeck, 2006 .

Anticancer activity of BIM-46174, a new inhibitor of the heterotrimeric Galpha/Gbetagamma protein complex.

D. Zaharevitz, E. Bruyneel, S. Holbeck, 2006, Cancer research.

Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) - Phase 2 Study of MLN0128 (TAK-228) in Patients with Tumors with TSC1 or TSC2 Mutations: Sub-protocol EAY131-M

G. Iyer, P. Paik, B. Conley, 2022, European Journal of Cancer.